Items where authors include "Henry, AM"

Article

Holch, P, Absolom, KL orcid.org/0000-0002-5477-6643, Henry, AM orcid.org/0000-0002-5379-6618 et al. (18 more authors) (2023) Online symptom monitoring during pelvic radiotherapy: randomised pilot trial of eRAPID intervention. International Journal of Radiation: Oncology - Biology - Physics, 115 (3). pp. 664-676. ISSN 0360-3016

Slevin, F orcid.org/0000-0002-7176-904X, Rieu, R, Beasley, M et al. (10 more authors) (2023) Evaluation of the impact of teaching on delineation variation during a virtual stereotactic ablative radiotherapy contouring workshop. Journal of Radiotherapy in Practice, 22. e19. ISSN 1460-3969

Bird, D orcid.org/0000-0001-6775-3603, Pearce, S, Teo, M et al. (8 more authors) (2022) Assessing the patient experience of anal and rectal cancer MR simulation for radiotherapy treatment planning. Journal of Radiotherapy in Practice, 21 (4). pp. 487-492. ISSN 1460-3969

Gilbert, DC, Henry, AM orcid.org/0000-0002-5379-6618 and Choudhury, A (2022) Marginal Gains and Clinical Trials – Improving and Influencing Practice. Clinical Oncology, 34 (7). pp. 419-420. ISSN 0936-6555

Willemse, P-PM, Davis, NF, Grivas, N et al. (35 more authors) (2022) Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy. European Urology, 81 (4). pp. 337-346. ISSN 0302-2838

Dearnaley, D, Hinder, V, Hijab, A et al. (26 more authors) (2022) Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial. The Lancet Oncology. ISSN 1470-2045

Bird, D, Nix, MG, McCallum, H et al. (9 more authors) (2021) The benefit of MR-only radiotherapy treatment planning for anal and rectal cancers: A planning study. Journal of Applied Clinical Medical Physics, 22 (11). pp. 41-53. ISSN 1526-9914

Bird, D orcid.org/0000-0001-6775-3603, Speight, R, Al-Qaisieh, B et al. (1 more author) (2021) Magnetic Resonance Imaging Simulation for Anal and Rectal Cancer – Optimising the Patient Experience. Clinical Oncology, 33 (10). E422-E424. ISSN 0936-6555

Zhong, J orcid.org/0000-0001-5325-3739, Slevin, F, Scarsbrook, AF orcid.org/0000-0002-4243-032X et al. (5 more authors) (2021) Salvage Reirradiation Options for Locally Recurrent Prostate Cancer: A Systematic Review. Frontiers in Oncology, 11. 681448. 681448-. ISSN 2234-943X

Slevin, F orcid.org/0000-0002-7176-904X, Beasley, M, Zhong, J et al. (5 more authors) (2021) A feasibility study of hyoscine butylbromide (buscopan) to improve image quality of cone beam computed tomography during abdominal/pelvic Stereotactic Ablative Radiotherapy. BJR open, 3 (1). 20210045. p. 20210045. ISSN 2513-9878

Bird, D, Beasley, M, Nix, MG et al. (11 more authors) (2021) Patient position verification in magnetic-resonance imaging only radiotherapy of anal and rectal cancers. Physics and Imaging in Radiation Oncology, 19. pp. 72-77. ISSN 2405-6316

Slevin, F orcid.org/0000-0002-7176-904X and Henry, AM orcid.org/0000-0002-5379-6618 (2021) Muscle-invasive Bladder Cancer in the Elderly Patient With a Focus on Hypofractionated Radiotherapy. Clinical Oncology, 33 (6). pp. 369-375. ISSN 0936-6555

Bates, AS, Ayers, J, Kostakopoulos, N et al. (30 more authors) (2021) A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research. European Urology Oncology, 4 (3). pp. 405-423. ISSN 2588-9311

Bird, D, Nix, MG, McCallum, H et al. (9 more authors) (2021) Multicentre, deep learning, synthetic-CT generation for ano-rectal MR-only radiotherapy treatment planning. Radiotherapy and Oncology, 156. pp. 23-28. ISSN 0167-8140

Cornford, P, van den Bergh, RCN, Briers, E et al. (24 more authors) (2021) EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. European Urology, 79 (2). pp. 263-282. ISSN 0302-2838

Mottet, N, van den Bergh, RCN, Briers, E et al. (24 more authors) (2021) EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. European Urology, 79 (2). pp. 243-262. ISSN 0302-2838

Slevin, F, Sethugavalar, B, Al-Qaisieh, B et al. (5 more authors) (2020) Ten-year longitudinal health-related quality of life following iodine-125 brachytherapy monotherapy for localized prostate cancer. Journal of Contemporary Brachytherapy, 12 (6). pp. 540-546. ISSN 1689-832X

Slevin, F, Rodda, SL, Bownes, P et al. (10 more authors) (2020) Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’. Clinical and Translational Radiation Oncology, 24. p. 52. ISSN 2405-6308

Witjes, JA, Babjuk, M, Bellmunt, J et al. (119 more authors) (2020) Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250]. European Urology, 78 (1). e48-e50. ISSN 0302-2838

Slevin, F, Hodgson, S, Rodda, SL et al. (9 more authors) (2020) Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer. Clinical and Translational Radiation Oncology, 23. pp. 20-26. ISSN 2405-6308

Moris, L, Cumberbatch, MG, Van den Broeck, T et al. (29 more authors) (2020) Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. European Urology, 77 (5). pp. 614-627. ISSN 0302-2838

Van den Broeck, T, van den Bergh, RCN, Briers, E et al. (21 more authors) (2020) Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations. European Urology Focus, 6 (2). pp. 231-234. ISSN 2405-4569

Witjes, JA, Babjuk, M, Bellmunt, J et al. (118 more authors) (2020) EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees. European Urology, 77 (2). pp. 223-250. ISSN 0302-2838

Slevin, F, Rodda, SL, Bownes, P et al. (10 more authors) (2020) A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapy. Clinical and Translational Radiation Oncology, 20. pp. 1-8. ISSN 2405-6308

Lam, TBL, MacLennan, S, Willemse, P-PM et al. (66 more authors) (2019) EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study). European Urology, 76 (6). pp. 790-813. ISSN 0302-2838

Bird, D, Henry, AM orcid.org/0000-0002-5379-6618, Sebag-Montefiore, D orcid.org/0000-0002-5978-9259 et al. (3 more authors) (2019) A Systematic Review of the Clinical Implementation of Pelvic Magnetic Resonance Imaging (MR)-Only Planning for External Beam Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics, 105 (3). pp. 479-492. ISSN 0360-3016

Horwich, A, Babjuk, M, Bellmunt, J et al. (118 more authors) (2019) EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees. Annals of Oncology, 30 (11). pp. 1697-1727. ISSN 0923-7534

Van den Broeck, T, Van den Bergh, RCN, Arfi, N et al. (25 more authors) (2019) Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. European Urology, 75 (6). pp. 967-987. ISSN 0302-2838

Lam, TBL, MacLennan, S, Plass, K et al. (37 more authors) (2019) Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer. European Urology, 75 (4). pp. 699-702. ISSN 0302-2838

van der Poel, HG, van den Bergh, RCN, Briers, E et al. (11 more authors) (2019) Reply to Massimo Valerio, Mark Emberton, and Hashim U. Ahmed's Letter to the Editor re: Henk G. van der Poel, Roderick C.N. van den Bergh, Erik Briers, et al. Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018. Eur Urol 2018;74:84–91. European Urology, 75 (2). e23-e24. ISSN 0302-2838

Parikh, S, Murray, L orcid.org/0000-0003-0658-6455, Kenning, L et al. (10 more authors) (2018) Real-world Outcomes and Factors Predicting Survival and Completion of Radium 223 in Metastatic Castrate-resistant Prostate Cancer. Clinical Oncology, 30 (9). pp. 548-555. ISSN 0936-6555

van der Poel, HG, van den Bergh, RCN, Briers, E et al. (10 more authors) (2018) Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018. European Urology, 74 (1). pp. 84-91. ISSN 0302-2838

Holch, P, Pini, S, Henry, AM orcid.org/0000-0002-5379-6618 et al. (9 more authors) (2018) eRAPID electronic patient self-Reporting of Adverse-events: Patient Information and aDvice: a pilot study protocol in pelvic radiotherapy. Pilot and Feasibility Studies, 4. 110. ISSN 2055-5784

Johnstone, E, Wyatt, JJ, Henry, AM orcid.org/0000-0002-5379-6618 et al. (6 more authors) (2018) Systematic Review of Synthetic Computed Tomography Generation Methodologies for Use in Magnetic Resonance Imaging–Only Radiation Therapy. International Journal of Radiation Oncology - Biology - Physics, 100 (1). pp. 199-217. ISSN 0360-3016

Lardas, M, Liew, M, van den Bergh, R et al. (21 more authors) (2017) Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review. European Urology, 72 (6). pp. 869-885. ISSN 0302-2838

Murray, LJ orcid.org/0000-0003-0658-6455, Lilley, J, Hawkins, MA et al. (3 more authors) (2017) Pelvic re-irradiation using stereotactic ablative radiotherapy (SABR): A systematic review. Radiotherapy and Oncology, 125 (2). pp. 213-222. ISSN 0167-8140

Moldovan, PC, Van den Broeck, T, Sylvester, R et al. (21 more authors) (2017) What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel. European Urology, 72 (2). pp. 250-266. ISSN 0302-2838

Fossati, N, Willemse, P-PM, Van den Bergh, RCN et al. (19 more authors) (2017) The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review. European Urology, 72 (1). pp. 84-109. ISSN 0302-2838

Mottet, N, Bellmunt, J, Bolla, M et al. (19 more authors) (2017) EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. European urology, 71 (4). pp. 618-629. ISSN 0302-2838

Cornford, P, Bellmunt, J, Bolla, M et al. (12 more authors) (2017) EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer. European urology, 71 (4). pp. 630-642. ISSN 0302-2838

Murray, L orcid.org/0000-0003-0658-6455, Mason, J, Henry, AM orcid.org/0000-0002-5379-6618 et al. (4 more authors) (2016) Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer. Radiotherapy and Oncology, 120 (2). pp. 293-299. ISSN 0167-8140

Mason, J, Mamo, A, Al-Qaisieh, B et al. (2 more authors) (2016) Real-time in vivo dosimetry in high dose rate prostate brachytherapy. Radiotherapy and Oncology, 120 (2). pp. 333-338. ISSN 0167-8140

Henry, AM, Summers, H, Murray, L et al. (7 more authors) (2016) Evaluating the need for adaptive therapy when delivering conformal bladder radiotherapy. Journal of Radiotherapy in Practice, 15 (1). pp. 15-22. ISSN 1460-3969

Wolff, RF, Ryder, S, Bossi, A et al. (11 more authors) (2015) A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer. European Journal of Cancer, 51 (16). pp. 2354-2367. ISSN 0959-8049

Henry, AM, Rodda, SL, Mason, M et al. (7 more authors) (2015) The Effect of Dose and Quality Assurance in Early Prostate Cancer Treated with Low Dose Rate Brachytherapy as Monotherapy. Clinical Oncology, 27 (7). 382 - 386. ISSN 0936-6555

Murray, LJ orcid.org/0000-0003-0658-6455, Thompson, CM, Lilley, J et al. (4 more authors) (2015) Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy. Physics in Medicine and Biology, 60 (3). pp. 1237-1257. ISSN 0031-9155

Murray, LJ orcid.org/0000-0003-0658-6455, Cosgrove, V, Lilley, J et al. (5 more authors) (2014) Developing a class solution for Prostate Stereotactic Ablative Body Radiotherapy (SABR) using Volumetric Modulated Arc Therapy (VMAT). Radiotherapy and Oncology, 110 (2). pp. 298-302. ISSN 0167-8140

Proceedings Paper

Slevin, F, Beasley, M, Needham, A et al. (4 more authors) (2019) Image quality of cone beam CT used as image-guidance for pelvic Stereotactic Ablative Radiotherapy. In: Radiotherapy and Oncology. ESTRO 38, 26-30 Apr 2019, Milan, Italy. Elsevier BV , S303-S303.

Slevin, F, Beasley, M, Lilley, J et al. (3 more authors) (2019) Inter and intra-fraction bowel motion during abdomino-pelvic stereotactic ablative radiotherapy. In: Radiotherapy and Oncology. ESTRO 38, 26-30 Apr 2019, Milan, Italy. Elsevier BV , S1082-S1083.